NO902600L - Fremgangsmaate og mellomprodukt for fremstilling av tigogenin beta-cellobiosid. - Google Patents
Fremgangsmaate og mellomprodukt for fremstilling av tigogenin beta-cellobiosid.Info
- Publication number
- NO902600L NO902600L NO90902600A NO902600A NO902600L NO 902600 L NO902600 L NO 902600L NO 90902600 A NO90902600 A NO 90902600A NO 902600 A NO902600 A NO 902600A NO 902600 L NO902600 L NO 902600L
- Authority
- NO
- Norway
- Prior art keywords
- cellobioside
- preparation
- tigogenin
- beta
- tigogenin beta
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
- C07H15/20—Carbocyclic rings
- C07H15/24—Condensed ring systems having three or more rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H13/00—Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids
- C07H13/12—Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids by acids having the group -X-C(=X)-X-, or halides thereof, in which each X means nitrogen, oxygen, sulfur, selenium or tellurium, e.g. carbonic acid, carbamic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J53/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton has been modified by condensation with a carbocyclic rings or by formation of an additional ring by means of a direct link between two ring carbon atoms, including carboxyclic rings fused to the cyclopenta(a)hydrophenanthrene skeleton are included in this class
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J71/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton is condensed with a heterocyclic ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J71/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton is condensed with a heterocyclic ring
- C07J71/0005—Oxygen-containing hetero ring
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Life Sciences & Earth Sciences (AREA)
- Molecular Biology (AREA)
- Genetics & Genomics (AREA)
- Biotechnology (AREA)
- Biochemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Animal Behavior & Ethology (AREA)
- Urology & Nephrology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Vascular Medicine (AREA)
- Medicinal Chemistry (AREA)
- Saccharide Compounds (AREA)
- Steroid Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Polysaccharides And Polysaccharide Derivatives (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Compounds Of Unknown Constitution (AREA)
- Catalysts (AREA)
- Ultra Sonic Daignosis Equipment (AREA)
- Mechanical Treatment Of Semiconductor (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US07/365,588 US5010185A (en) | 1989-06-13 | 1989-06-13 | Processes for tigogenin beta-cellobioside |
Publications (2)
Publication Number | Publication Date |
---|---|
NO902600D0 NO902600D0 (no) | 1990-06-12 |
NO902600L true NO902600L (no) | 1990-12-14 |
Family
ID=23439483
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO90902600A NO902600L (no) | 1989-06-13 | 1990-06-12 | Fremgangsmaate og mellomprodukt for fremstilling av tigogenin beta-cellobiosid. |
Country Status (23)
Country | Link |
---|---|
US (1) | US5010185A (ja) |
EP (1) | EP0403150B1 (ja) |
JP (1) | JPH0637514B2 (ja) |
KR (1) | KR920002146B1 (ja) |
AT (1) | ATE114155T1 (ja) |
AU (1) | AU619986B2 (ja) |
CA (1) | CA2018722A1 (ja) |
CZ (1) | CZ279909B6 (ja) |
DD (1) | DD295164A5 (ja) |
DE (1) | DE69014152T2 (ja) |
DK (1) | DK0403150T3 (ja) |
ES (1) | ES2063269T3 (ja) |
FI (1) | FI902937A0 (ja) |
HU (1) | HU210689B (ja) |
IE (1) | IE64057B1 (ja) |
IL (1) | IL94650A (ja) |
NO (1) | NO902600L (ja) |
NZ (1) | NZ234028A (ja) |
PL (3) | PL163258B1 (ja) |
PT (1) | PT94337A (ja) |
RU (1) | RU2042688C1 (ja) |
YU (1) | YU47515B (ja) |
ZA (1) | ZA904527B (ja) |
Families Citing this family (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5294703A (en) * | 1992-05-01 | 1994-03-15 | Eastman Kodak Company | Process for preparing α-D-cellobiose octaacetate |
AU4044293A (en) * | 1992-06-26 | 1994-01-24 | Pfizer Inc. | Process for steroidal peracyl glycosides |
CA2138016A1 (en) * | 1992-06-26 | 1994-01-06 | Kathleen D. Goggin | Steroidal beta-o-cellobioside heptaalkanoate process |
AU4226593A (en) * | 1992-06-26 | 1994-01-24 | Pfizer Inc. | Steroidal glycosides for treating hypercholesterolemia |
US5530107A (en) * | 1992-10-15 | 1996-06-25 | Pfizer Inc. | Method for making steroidal peracyl glycosides |
EP0696292A1 (en) * | 1993-04-28 | 1996-02-14 | Pfizer Inc. | Spirostanyl glycosidal crystalline monohydrate |
US5502038A (en) * | 1993-06-21 | 1996-03-26 | Medical Research Foundation Of Oregon | Cholesterol sequestrant glycosides that inhibit intestinal cholesterol absorption |
ES2074006B1 (es) * | 1993-07-05 | 1996-03-16 | Pfizer | Glicosidos esteroidales para tratar hipercolesterolemia. |
WO2004007370A1 (ja) * | 2002-07-12 | 2004-01-22 | Shionogi Co., Ltd. | 酸触媒として機能するゼオライト類似体の簡易な製造法 |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4602005A (en) * | 1982-05-17 | 1986-07-22 | Medical Research Foundation Of Oregon | Tigogenin cellobioside for treating hypercholesterolemia and atherosclerosis |
US4602003A (en) * | 1982-05-17 | 1986-07-22 | Medical Research Foundation Of Oregon | Synthetic compounds to inhibit intestinal absorption of cholesterol in the treatment of hypercholesterolemia |
-
1989
- 1989-06-13 US US07/365,588 patent/US5010185A/en not_active Expired - Fee Related
-
1990
- 1990-06-06 DK DK90306143.0T patent/DK0403150T3/da active
- 1990-06-06 DE DE69014152T patent/DE69014152T2/de not_active Expired - Fee Related
- 1990-06-06 JP JP2148456A patent/JPH0637514B2/ja not_active Expired - Lifetime
- 1990-06-06 EP EP90306143A patent/EP0403150B1/en not_active Expired - Lifetime
- 1990-06-06 IL IL9465090A patent/IL94650A/en not_active IP Right Cessation
- 1990-06-06 AT AT90306143T patent/ATE114155T1/de not_active IP Right Cessation
- 1990-06-06 ES ES90306143T patent/ES2063269T3/es not_active Expired - Lifetime
- 1990-06-11 CZ CS902890A patent/CZ279909B6/cs not_active IP Right Cessation
- 1990-06-11 CA CA002018722A patent/CA2018722A1/en not_active Abandoned
- 1990-06-11 PT PT94337A patent/PT94337A/pt not_active Application Discontinuation
- 1990-06-12 HU HU903816A patent/HU210689B/hu not_active IP Right Cessation
- 1990-06-12 NO NO90902600A patent/NO902600L/no unknown
- 1990-06-12 AU AU57079/90A patent/AU619986B2/en not_active Ceased
- 1990-06-12 PL PL90289135A patent/PL163258B1/pl unknown
- 1990-06-12 KR KR1019900008599A patent/KR920002146B1/ko not_active IP Right Cessation
- 1990-06-12 YU YU114590A patent/YU47515B/sh unknown
- 1990-06-12 FI FI902937A patent/FI902937A0/fi not_active IP Right Cessation
- 1990-06-12 RU SU904830049A patent/RU2042688C1/ru active
- 1990-06-12 NZ NZ234028A patent/NZ234028A/xx unknown
- 1990-06-12 DD DD90341563A patent/DD295164A5/de not_active IP Right Cessation
- 1990-06-12 PL PL90285593A patent/PL163219B1/pl unknown
- 1990-06-12 PL PL90289136A patent/PL163259B1/pl unknown
- 1990-06-12 IE IE210190A patent/IE64057B1/en not_active IP Right Cessation
- 1990-06-12 ZA ZA904527A patent/ZA904527B/xx unknown
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE122004000017I1 (de) | Monoklonaler Antik¦rper gegen ein Cytotoxin, denselben erzeugendes Hybridoma und Verfahren f}r die Herstellung des gereinigten Cytotoxin. | |
DE69007764D1 (de) | Packungsmaterial für umgekehrte Phasechromatographie und Verfahren zu dessen Herstellung. | |
DE59003581D1 (de) | Hochtemperatur-Verbund-Werkstoff, Verfahren zu seiner Herstellung sowie dessen Verwendung. | |
JPS51129340A (en) | Method of producing clogs | |
NO902600L (no) | Fremgangsmaate og mellomprodukt for fremstilling av tigogenin beta-cellobiosid. | |
FR2700770B1 (fr) | Procédé de fabrication du 1,1,1,2-tétrafluoro-2-chloroéthane et du pentafluoroéthane. | |
ATE199559T1 (de) | N- und o-substituierte aminophenolderivate, zwischenprodukte zu deren herstellung, deren verwendung als hydrolasesubstrate, ein entsprechendes bestimmungsverfahren und hierfür geeignetes diagnostisches mittel | |
DE69502571T2 (de) | Prozess für die Herstellung von fermentierbarem Material | |
HUT57753A (en) | Process for producing benzthiazoles usable as anthelminic and their intermediates | |
EP0953611A4 (en) | REPELLENT-CONTAINING MATERIAL FOR ELECTRONIC COMPONENTS, ELECTRONIC COMPONENTS MANUFACTURED FROM SUCH MATERIAL, AND PROCESS FOR PRODUCING SUCH COMPONENTS | |
EG22746A (en) | Process and intermediates for the manufacture of pyridine 2,3 dicarboxylate compounds | |
PT77825A (de) | Neue 2-azabicyclo<2.2.1>heptan-derivate verfahren zu ihrer herstellung diese enthaltende mittel und deren verwendung sowie 2-azabicyclo/2.2.1/heptan-derivate als zwischenprodukte und verfahren zu deren herstellung | |
DE69013722D1 (de) | Nichtrostende Stahlbleche für Gebäudeaussenteile und Verfahren zum Herstellen derselben. | |
HUT46077A (en) | Process for the microbiological production of 9alpha-hydroxy-4-androsten-3,17-dione | |
DE59409540D1 (de) | Präkeramische Polyborosilazane, Verfahren zu deren Herstellung sowie daraus erhältliches keramisches Material | |
GR3001086T3 (en) | Substituted dioxanones, method for preparing same and use thereof | |
YU40849B (en) | Process for obtaining 1,3-benzoxazine-2,4-dione derivatives | |
IL100033A0 (en) | Process for the production of 4,5,6,7-tetrahydroimidazo-(4,5,ljk)(1,4)-benzodiazepine-2-(1h)-thiones as well as intermediate products | |
DE3461790D1 (en) | Process for the production of partially hydrogenated derivatives of 2-nitro-1,1,1-trifluoralkanes | |
IL63482A0 (en) | 4-lower alkyl-3-phenoxypyridine-1-oxide and a method for its production | |
ATA98987A (de) | Verfahren zum herstellen von stuetzausbauten im grosstunnel- bzw. stollenbau und nach diesem verfahren hergestellte stuetzausbauten | |
DE69302950D1 (de) | Verfahren zur Herstellung von Stahlblechen und Stahlbleche, nach diesem Verfahren hergestellt | |
DD138648A1 (de) | Steatitaehnlicher,temperaturwechselbestaendiger,ker&mischer werkstoff und verfahren zu seiner herstellung | |
DE69617014D1 (de) | Verfahren zum Herstellen von Verbundwerkstoffen | |
DE69011653D1 (de) | Optisch aktive Verbindung, Intermediate hierzu, Verfahren zur Herstellung der Intermediate, und flüssigkristalline Zusammensetzung. |